Status:
COMPLETED
Lymphedema Study for Arm or Leg Lymphedema
Lead Sponsor:
Stanford University
Conditions:
Lymphedema
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.
Detailed Description
Part 1 is feasibility, exploratory, open-label study of ketoprofen, to document effects. Part 2, is open-label trial of ketoprofen to document histological response. Part 3 is double-blind randomized...
Eligibility Criteria
Inclusion
- a history of lymphedema of one or more limbs (unilateral or bilateral), with a duration of \> 6 months.
Exclusion
- Patients with active cancer, infection or bleeding tendency will be excluded.
- We will also exclude patients with medical contraindications to NSAIDs, including history of allergies, know gastrointestinal intolerance, or other serious systemic illness (e.g., renal failure, hepatic dysfunction, congestive heart failure, neurological or psychological impairment) that would impair the patients' ability to participate.
- Minors (\<18 years of age) \*\>90 years of age
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT02257970
Start Date
March 1 2009
End Date
March 1 2017
Last Update
October 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305